Vantage BioTrials at BioNJ BioPartnering 2026
Vantage BioTrials will attend the BioNJ BioPartnering Conference on May 12, 2026 in New Jersey, as part of the BioQuébec delegation.
This event brings together biotechnology companies, pharmaceutical organizations, investors, and service providers. It creates a valuable setting for collaboration and discussion across the life sciences ecosystem.
As clinical programs become more complex, early alignment between sponsors and CRO partners is increasingly important. As a result, strong operational planning and clear communication are essential for successful trial execution.
Representing Vantage BioTrials
Vatche Bartekian, President of Vantage BioTrials, will attend the conference.
As a member of BioQuébec, Vantage BioTrials is pleased to join the Québec delegation once again. This participation highlights the strength of Québec’s life sciences ecosystem and its growing role in global clinical research.
Full-Service Clinical Trial Management Expertise
Vantage BioTrials has supported sponsors for nearly two decades. Our model focuses on structured, full-service clinical trial management.
Our capabilities include:
- Clinical project management and oversight
- Risk-based monitoring
- Quality management systems
- Study start-up and site coordination
- Vendor oversight
- Management of complex and late-phase programs
In addition, our approach is grounded in Quality by Design (QbD) principles. It also includes proactive risk mitigation from the earliest stages of development. Therefore, potential challenges are identified early and managed effectively throughout the study.
👉 Learn more about our therapeutic expertise.
Supporting Clinical Development in a Changing Landscape
Today, clinical development is evolving rapidly. Consequently, sponsors are looking for CRO partners who can provide both execution and strategic support.
At BioNJ, we look forward to discussing key topics such as:
- Managing complexity across clinical programs
- Supporting lean sponsor teams
- Maintaining data quality and patient safety
- Applying structured, risk-based approaches
These discussions are critical. They help ensure that promising therapies move forward efficiently while maintaining high standards.
About BioNJ BioPartnering
The BioNJ BioPartnering Conference is a leading life sciences event in the United States. It brings together innovators, investors, and partners to support collaboration and growth.
👉 Learn more: https://www.bionj.org/
Connect with Vantage BioTrials
If you plan to attend BioNJ BioPartnering 2026, we would welcome the opportunity to connect.
We would be pleased to discuss how structured clinical trial management, proactive risk mitigation, and collaborative execution can support your development programs.